Advancing state-of-the-art precision medicine
OncXerna is transforming precision medicine beyond single genetic mutations by discovering the dominant biology of a person’s cancer at the RNA level through its Xerna™️ RNA-based biomarker platform to advance more meaningful treatments for more cancer patients.
No one should go through their journey with cancer alone.
People with cancer, caregivers, and loved ones can find others to lean on and experts in the oncology community through numerous organizations for information, education, clinical and translational research, and support. More information can be found through these following groups: